Funding continues for Lawrence Pfeffer’s glioblastoma research through a three-year grant of $458,595 from the National Cancer Institute, in collaboration with Steven Ripp, PhD, research associate professor at the University of Tennessee at Knoxville. For more than 30 years, Pfeffer, PhD, the Muirhead Professor in the Department of Pathology in the College of Medicine at the University… Read More
Finding better treatment options for glioblastoma is personal for Lawrence Pfeffer, PhD, the Muirhead Professor in the Department of Pathology in the College of Medicine at the University of Tennessee Health Science Center. He became interested in the brain cancer, when a friend and former colleague passed away suddenly from the disease. Since then, he… Read More
Despite advances in surgery and therapy, Glioblastoma (GBM) remains the most common and deadliest brain cancer in adults. Research shows that Glioblastoma tumor recurrence and therapeutic resistance has been attributed to Glioma-Initiating Cells (GICs) within the tumor that display several characteristics of neural stem cells. “With a median patient survival rate between 10-15 months, identifying… Read More
